APGE
Apogee Therapeutics, Inc. · Healthcare
Insiders sold $20.3M net in the last 90 days ·2 sellers, 0 buyers· 7 of 7 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 8, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$174.0M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 3, 2026
Dambkowski Carl
Apogee Therapeutics, Inc. (APGE) has 47 SEC Form 4 filings (108 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 3, 2026.
Inside the rolling window, 4 insiders at Apogee Therapeutics, Inc. reported no open-market purchases and 36 open-market sales totaling $174.0M. The most active filer is Chief Financial Officer Henderson Jane with 13 filings. Insiders have net sold $26.7M over the trailing 6 months. The most recent open-market filing is a sale of 5,500 shares by Chief Medical Officer Dambkowski Carl, dated Aug 5, 2026, worth $738K.
- Industry:Biotechnology
- CEO:Michael Thomas Henderson
- Employees:261
- HQ:Waltham, MA, US
- IPO:2023-07-14
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 5,500 | $738K | Aug 8 | +0.3% | SEC ↗ | |
| Chief Executive Officer | Sale | 20,000 | $2.7M | Jul 11 | +0.9% | SEC ↗ | |
| Chief Medical Officer | Sale | 5,500 | $730K | Jul 2 | +1.6% | SEC ↗ | |
| Chief Medical Officer | Sale | 26,400 | $3.5M | Jun 25 | +1.8% | SEC ↗ | |
| Chief Executive Officer | Sale | 80,000 | $10.6M | Jun 25 | +1.8% | SEC ↗ | |
| Chief Executive Officer | Sale | 20,000 | $1.7M | Jun 12 | +52.9% | SEC ↗ | |
| Chief Medical Officer | Sale | 5,500 | $433K | Jun 6 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 20,000 | $1.6M | May 15 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 5,500 | $463K | May 8 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 2,000 | $164K | May 5 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 2,000 | $180K | Apr 17 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 20,000 | $1.7M | Apr 10 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 5,500 | $467K | Apr 3 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 2,000 | $170K | Apr 3 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 2,000 | $170K | Mar 27 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 20,000 | $1.5M | Mar 13 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 5,500 | $391K | Mar 6 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 2,000 | $140K | Mar 4 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 20,000 | $1.3M | Feb 13 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 5,500 | $362K | Feb 4 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 2,000 | $132K | Feb 4 | — | SEC ↗ | |
| Director | Sale | 1,750,000 | $133.5M | Jan 22 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 20,000 | $1.6M | Jan 16 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 18,700 | $1.5M | Jan 9 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 6,000 | $449K | Jan 6 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does APGE have?
Apogee Therapeutics, Inc. (APGE) has 47 SEC Form 4 filings (108 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 3, 2026.
When was the most recent SEC Form 4 filing for APGE?
The most recent Form 4 filing for APGE on Tracefour is dated Sep 3, 2026.
Who is the most active insider at APGE?
The most active SEC Form 4 filer at APGE in the rolling window is Chief Financial Officer Henderson Jane, with 13 filings.
What is the net insider flow at APGE over the last 6 months?
Over the trailing 180 days, insiders at APGE have net sold $26.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at APGE in the current window?
Inside the rolling window, insiders at APGE bought $0 and sold $174.0M based on SEC Form 4 filings.
Can I get alerts for APGE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Apogee Therapeutics, Inc. (APGE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Apogee Therapeutics, Inc. is in the Healthcare sector.